🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT06592378
Recruiting Not applicable

Opioid Management for Discharged Emergency Department Patients

NCT06592378 · tracked via the Priya Life Science USA tracker
Sponsor
Addinex Technologies, Inc.
Phase
Not applicable
Started
2025-06-27
Last updated
2025-12-26

Condition(s) studied

Bone Fractures

Investigational drug(s) / intervention(s)

AddinexStandard Pill Bottle

Addinex: Medication dispensing system to control and monitor opioid use

Standard Pill Bottle: Access and use of opioids in a standard pill bottle.

Study summary

The goal of this study is to analyze the use of the Addinex system for opioid dispensing after ambulatory care to determine whether it will reduce opioid consumption, increase pill disposal, show variables that may predict opioid consumption, and determine whether this intervention is acceptable to patients.

Eligibility

Sex
ALL
Min age
6 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Ages six years and older * Ability to swallow pills * Isolated bone fracture * Planned to receive opioids in the post-treatment period * Not taking opioids daily prior to the procedure * English or Spanish-speaking * Able to give informed consent or a parent that can give informed consent * Ownership of and comfort using apps on a smartphone with compatible operating system * WIFI or cellular access * Patient not admitted to hospital Exclusion Criteria: * Recent opioid use (last 30 days or 2 or more prescriptions in the past 3 months * Impaired decisional capacity * In police custody * Ward of the state

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Rhode Island Hospital/Lifespan Providence Rhode Island Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06592378 on ClinicalTrials.gov ↗ ← All trials in the USA